loadpatents
Patent applications and USPTO patent grants for Andersen; Birgitte.The latest application filed is for "method for modifying a lipase".
Patent | Date |
---|---|
Method for modifying characteristics of a lipase Grant 10,851,356 - Reiser , et al. December 1, 2 | 2020-12-01 |
Method For Modifying A Lipase App 20190153410 - Reiser; Anna Verena ;   et al. | 2019-05-23 |
Method for modifying characteristics of a lipase Grant 10,221,404 - Reiser , et al. | 2019-03-05 |
FGF21 derivatives and uses thereof Grant 10,124,039 - Wieczorek , et al. November 13, 2 | 2018-11-13 |
FGF21 Derivatives and Uses Thereof App 20180140673 - Wieczorek; Birgit ;   et al. | 2018-05-24 |
FGF21 derivatives and uses thereof Grant 9,895,417 - Wieczorek , et al. February 20, 2 | 2018-02-20 |
FGF21 Derivatives and Uses Thereof App 20170354713 - Wieczorek; Birgit ;   et al. | 2017-12-14 |
Oral treatment of inflammatory bowel disease Grant 9,833,495 - Rosenkilde Kj.ae butted.r , et al. December 5, 2 | 2017-12-05 |
FGF21 derivatives and uses thereof Grant 9,744,213 - Wieczorek , et al. August 29, 2 | 2017-08-29 |
FGF21 Derivatives and Uses Thereof App 20170182124 - Wieczorek; Birgit ;   et al. | 2017-06-29 |
A Method for Modifying A Lipase App 20170137794 - Reiser; Anna Verena ;   et al. | 2017-05-18 |
FGF21 derivatives with albumin binder A-B-C-D-E- and their use Grant 9,480,753 - Tagmose , et al. November 1, 2 | 2016-11-01 |
Oral Treatment Of Inflammatory Bowel Disease App 20160129081 - Rosenkilde Kj.ae butted.r; Tanja Maria ;   et al. | 2016-05-12 |
Treatment of inflammatory bowel diseases with mammal beta defensins Grant 9,279,010 - Kjaer , et al. March 8, 2 | 2016-03-08 |
Oral treatment of inflammatory bowel disease Grant 9,217,021 - Rosenkilde Kj.ae butted.r , et al. December 22, | 2015-12-22 |
Treatment of inflammatory bowel diseases with mammal beta defensins Grant 8,802,621 - Kjaer , et al. August 12, 2 | 2014-08-12 |
Oral Treatment of Inflammatory Bowel Disease App 20140213521 - Rosenkilde Kj.ae butted.r; Tanja Maria ;   et al. | 2014-07-31 |
Treatment of Inflammatory Bowel Diseases with Mammal Beta Defensins App 20140135258 - Kjaer; Tanja Maria Rosenkilde ;   et al. | 2014-05-15 |
Fgf21 Analogues And Derivatives App 20130252884 - Garibay; Patrick William ;   et al. | 2013-09-26 |
N-terminal Modified Fgf21 Compounds App 20130190232 - Tagmose; Tina Moeller ;   et al. | 2013-07-25 |
Oral Treatment Of Inflammatory Bowel Disease App 20130172235 - Kjaer; Tanja Maria Rosenkilde ;   et al. | 2013-07-04 |
Novel Immunomodulatory Peptide App 20130052213 - Kjaer; Tanja Maria Rosenkilde ;   et al. | 2013-02-28 |
Treatment of Rheumatoid Arthritis With Mammal Beta Defensins App 20120309686 - Kjaer; Tanja Maria Rosenkilde ;   et al. | 2012-12-06 |
Treatment of Inflammatory Bowel Diseases With Mammal Beta Defensins App 20120309678 - Kjaer; Tanja Maria Rosenkilde ;   et al. | 2012-12-06 |
Treatment of inflammatory bowel diseases with mammal beta defensins Grant 8,232,242 - Kjaer , et al. July 31, 2 | 2012-07-31 |
Treatment of rheumatoid arthritis with mammal beta defensins Grant 8,232,248 - Kjaer , et al. July 31, 2 | 2012-07-31 |
Glp-1 And Fgf21 Combinations For Treatment Of Diabetes Type 2 App 20120172298 - Andersen; Birgitte ;   et al. | 2012-07-05 |
Fgf21 Analogues And Derivatives App 20120035099 - GARIBAY; WILLIAM PATRICK ;   et al. | 2012-02-09 |
Treatment Of Inflammatory Bowel Diseases With Mammal Beta Defensins App 20110251139 - KJAER; TANJA MARIA ROSENKILDE ;   et al. | 2011-10-13 |
FGF21 Derivatives With Albumin Binder A-B-C-D-E- And Their Use App 20100216715 - Tagmose; Tina Moller ;   et al. | 2010-08-26 |
Treatment Of Rheumatoid Arthritis With Mammal Beta Defensins App 20100016231 - Kjaer; Tanja Maria Rosenkilde ;   et al. | 2010-01-21 |
Treatment Of Inflammatory Diseases With Mammal Beta Defensins App 20100016232 - Kjaer; Tanja Maria Rosenkilde ;   et al. | 2010-01-21 |
Treatment Of Inflammatory Bowel Diseases With Mammal Beta Defensins App 20100016230 - Kjaer; Tanja Maria Rosenkilde ;   et al. | 2010-01-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.